Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SABCS 2018 /
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients

4th - 8th Dec 2018

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 13.12.18
Views: 1167

Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands

Prof Emiel Rutgers speaks to ecancer at SABCS 2018 about the AMAROS trial looking into using radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients.

He explains that the main aim of the trial was to show that the auxiliary occurrence rates of lymph node metastasis was equal by both modalities and that the radiotherapy would involve less side effects.

Prof Rutgers explains that the 5 year results showed very low event rates in the axilla in both groups and much less side effects in the radiotherapy group however many were critical of the followup time being too short.

He reports that from the 10 year follow up the results show that the number of events is still really low, showing that both treatments are equal in regards to fighting the cancer.

Watch his press conference here.

Read more about this work here.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation